Acute Myeloid Leukemia — Trials

Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,962 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 789
Recruiting: 466
Ph III recruiting: 45
Growth YoY: +5%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (534)

clinicaltrialsPublishedShowing 2,951–2,962 of 2,962 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00089596	Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers	completed	Phase 1 / Phase 2	10	ViaCellINDUSTRY	1	Apr 12, 2007	clinicaltrials
NCT00161668	Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care	completed	—	500	Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY	1	Mar 15, 2007	clinicaltrials